How Cleveland Clinic cut time to treat in half for breast cancer patients
Efforts to address time to treat at Cleveland Clinic Cancer Center have cut almost in half the time breast cancer patients wait between diagnosis and treatment. Taussig Cancer Institute chairman Brian Bolwell, MD, FACP, discusses Cleveland Clinic Cancer Center’s commitment to reducing time to treat to less than half the national average across all diagnoses in the video below:
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Advertisement
Advertisement
Timing and type of side effects differ greatly from chemotherapy
Dedicated multidisciplinary teams support 84 ultra-rare cancers
Sessions explore treatment advances and multidisciplinary care
New research from Cleveland Clinic helps explain why these tumors are so refractory to treatment, and suggests new therapeutic avenues
Combination of olaparib and carboplatin results in complete durable response for a patient with BRCA2 and “BRCAness” mutations
Early communication between oncologists and ophthalmologist warranted
Case-based course delves into latest treatment approaches
Long-term relationship building and engagement key to gaining community trust